| Univariate analysis | Multivariate analysis1 | ||
---|---|---|---|---|
 | P | HR (95%CI) | P | HR (95%CI) |
MYC EC | 0.003 | 4.694 (1.697–12.988) | 0.002 | 8.068 (2.145–30.348) |
MYC R | 0.015 | 3.831 (1.302–11.277) | 0.028 | 8.005 (1.248–51.359) |
MYC expression | 0.290 | 1.590 (0.674–3.752) | 0.956 | 1.035 (0.307–3.491) |
BCL2 EC | 0.037 | 2.819 (1.063–7.472) | 0.172 | 2.901 (0.629–13.373) |
BCL2 R | 0.180 | 2.224 (0.691–7.155) | 0.106 | 0.089 (0.005–1.676) |
BCL2 expression | 0.390 | 1.614 (0.542–4.806) | 0.624 | 0.696 (0.163–2.966) |
BCL6 EC | 0.517 | 1.461 (0.465–4.592) | 0.434 | 1.683 (0.457–6.195) |
BCL6 R | 0.039 | 2.724 (1.049–7.069) | 0.550 | 1.454 (0.426–4.962) |
BCL6 expression | 0.585 | 0.768 (0.297–1.981) | 0.813 | 1.174 (0.310–4.446) |
Atypical DHL/THL | 0.001 | 9.054 (2.549–32.167) | 0.385 | 2.841 (0.269–29.957) |
DHL/THL | 0.004 | 7.011 (1.866–26.342) | 0.463 | 3.111 (0.150–64.521) |
DEL | 0.740 | 1.228 (0.366–4.124) | 0.825 | 0.809 (0.123–5.304) |
Age | 0.860 | 0.930 (0.417–2.077) | 0.442 | 2.167 (0.301–15.592) |
R-CHOP vs R-CHOPE & R-EPOCH | 0.731 | 0.840 (0.310–2.273) | 0.080 | 0.266 (0.061–1.169) |
IPI ≥ 3 | 0.021 | 3.618 (1.215–10.770) | 0.323 | 0.223 (0.011–4.367) |
Marrow involvement | 0.007 | 3.463 (1.415–8.475) | 0.011 | 4.163 (1.436–12.453) |
Ann Arbor stage > 2 | 0.044 | 7.926 (1.061–59.198) | 0.279 | 3.704(0.345–39.721) |
Extranodal sites ≥2 | 0.044 | 2.807(1.027–7.678) | 0.599 | 0.603(0.091–3.977) |
Elevated LDH | 0.050 | 2.610(0.999–6.819) | 0.260 | 2.470(0.512–11.920) |